MedPath

HEALTH RESEARCH, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

2

TGA:2

Drug Approvals

rhomanga tablets (259970)

Product Name
rhomanga tablets
Approval Date
Sep 14, 2015
TGA

PERCY'S POWDER (218522)

Product Name
PERCY'S POWDER
Approval Date
Dec 13, 2013
TGA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

Phase 4
Conditions
Osteoporosis
Interventions
Drug: Experimental Cyclic Regimen
Drug: Standard Clinical Practice Regimen
First Posted Date
2014-05-06
Last Posted Date
2017-08-31
Lead Sponsor
Health Research, Inc.
Target Recruit Count
60
Registration Number
NCT02130973
Locations
🇺🇸

Helen Hayes Hospital, West Haverstraw, New York, United States

Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur

Not Applicable
Completed
Conditions
Osteoporosis
Interventions
Other: placebo
First Posted Date
2011-03-07
Last Posted Date
2016-11-23
Lead Sponsor
Health Research, Inc.
Target Recruit Count
40
Registration Number
NCT01309399
Locations
🇺🇸

Helen Hayes Hospital, West Haverstraw, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.